A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial

Health Technology Assessment

Volumn 15, Issue 12, 2011, Pages

  Williams, L J ^a   Kunkler, I H ^b   King, C C ^a   Jack, W ^b   van der Pol, M ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANXIETY; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; ENDOCRINE DISEASE; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; LONG TERM CARE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; QUALITY OF LIFE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SURVIVAL RATE; SYMPTOM; TUMOR VOLUME; AGE DISTRIBUTION; ANOREXIA; ANXIETY DISORDER; APPLICATION SITE EDEMA; BREAST ATROPHY; BREAST EDEMA; BREAST FIBROSIS; BREAST SURGERY; CANCER PAIN; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COGNITION; CONSERVATIVE TREATMENT; CONSTIPATION; COST MINIMIZATION ANALYSIS; COUGHING; DATA ANALYSIS; DYSPNEA; EUROPEAN ORGANISATION FOR RESEARCH IN THE TREATMENT OF CANCER SCALE; FOLLOW UP; FUNCTIONAL STATUS; HAIR LOSS; INTERVIEW; LYMPH NODE METASTASIS; NAUSEA; OPEN ENDED QUESTIONNAIRE; QUALITATIVE RESEARCH; SELF REPORT; SEXUAL BEHAVIOR; SOCIAL STATUS; TELANGIECTASIA; TREATMENT OUTCOME; ULCER; UNITED KINGDOM; VOMITING;

AGED; ANXIETY; BREAST NEOPLASMS; CONFIDENCE INTERVALS; DEPRESSION; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HUMANS; MASTECTOMY, SEGMENTAL; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953127639     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta15120     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Office for National Statistics. Life expectancy. URL: www. statistics.gov.uk/cci/nugget. asp?id = 168 (accessed December 2010).
3. Cancer Research UK. Breast cancer-UK incidence statistics. URL: http://info. cancerresearchuk.org/cancerstats/types/breast/incidence/?a = 5441 (accessed December 2010).
4. Office for National Statistics. Life expectancy at birth and at age 65 by local areas in the United Kingdom, 2007-9. URL: www. statistics.gov.uk/pdfdir/liex1010.pdf (accessed December 2010).
5. Wyld L, Reed MWR. The need for targeted research into breast cancer in the elderly. Br J Surg 2003;90:388-99.
6. Cheung KL, Morgan DAL, Winterbottom L, Richardson H, Ellis IO, Porock D, A vision to optimise the management of primary breast cancer in older women. Breast 2010;19:153-5.
7. Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001;285:885-92.
8. Pierga JY, Girre V, Laurence V, Asselain B, Dieras V, Jouve M, et al. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast 2004;13:369-75.
9. Siegelmann-Danieli N, Khandelwal V, Wood GC, Mainali R, Prichard J, Murphy TJ, et al. Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 2006;7:59-66.
10. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet 2005;366:2087-106.
11. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus radiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
12. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17:2326-33.
13. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for nodenegative breast cancer:an update. J Natl Cancer Inst 1996;88:1659-64.
14. Veronesi U, Luini A, Delvecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
15. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 1996;348:708-13.
16. The Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 1990;82:277-82.
17. Clark RM, Mcculloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992;84:683-9.
18. Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J, et al. Sector resection with or without postoperative radiotherapy for stage-I breast cancer-5-year results of a randomized trial. J Natl Cancer Inst 1994;86:717-22.
19. Hughes KS, Schnapper LA, Berry D, Cirrincione C, McCormick B, Shank B, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-7.
20. Smith IE, Ross GM. Breast radiotherapy after lumpectomy-no longer always necessary? N Engl J Med 2004;351:1021-3.
21. Prescott RJ, Kunkler IH, Williams LJ, King CC, Jack W, van der Pol M, et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess 2007;11(31).
22. Kunkler IH. PRIME II. Breast cancer trial. Clin Oncol 2004;351:971-7.
23. The PRIME Breast Cancer Trial protocol. URL: http://homepages.ed.ac.uk/prime/PRIME1/ protocol_1.pdf
24. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
25. Sprangers MAG, Groenvold M, Arraras JI, Franklin J, teVelde A, Muller M, et al. The European Organisation for Research and Treatment of Cancer breast cancer-specific quality of life questionnaire module: First results from a three-country field study. J Clin Oncol 1996;14:2756-68.
26. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
27. Euroqol Group. Euroqol: A new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
28. Wolfinger R, O'Connell M. Generalised linear mixed models: a pseudo-likelihood approach. J Stat Comput Simul 1993;48:233-43.
29. Karnon J, Kerr GR, Jack W, Papo N, Cameron D. Health care costs for the treatment of breast cancer recurrent events:estimates from a UK-based patient-level analysis. Br J Cancer 2007;97:479-85.
30. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitundinal studies:development and validation. J Chron Dis 1987;40:373-83.
31. Abram WP, Clarke J, McAleer JJA, Graham JD, Riddle P, Goodman S, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 2008;9:331-41.
32. Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bliss JM. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer:a randomised trial. Lancet 2008;371:1098-107.
33. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-20.
34. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001;37:1345-51.
35. Kurtz J. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer 2002;38:1961-74.
36. Blamey RW, Chetty U, Bates T, George D, Mallon E, Oates AJ, et al. Radiotherapy and/or Tamoxifen after conserving surgery for breast cancers of excellent prognosis: BASO II trial. Eur J Cancer Suppl 2008;6:55.
37. Rozenberg S, Antoine C, Carly B, Pastijn A, Liebens F. Improving quality of life after breast cancer: prevention of other diseases. Menopause Int 2007;13:71-4.